Syntiron LLC Awarded a Qualifying Therapeutic Discovery Project (QTDP) Grant under the U.S. Patient Protection and Affordable Care Act of 2010
11/12/2010 8:39:15 AM
More...
|
Sanofi Pasteur (SASY.PA) (JOBS) Purchases Rights to Syntiron LLC's MRSA Vaccine; Sanofi Will Pay Syntiron Upfront Fee, Research Capital, and Several Milestone Payments That Could Reach $149 Million
12/16/2009 7:03:51 AM
More...
|
Syntiron LLC Receives Biotechnology Award at the 2008 Tekne Awards
11/11/2008 11:14:56 AM
More...
|
Syntiron LLC Receives Notification of a $3.8M Pending Contract from the United States Defense Threat Reduction Agency (DTRA) to Develop Bioterrorism Vaccines
10/23/2008 10:38:32 AM
More...
|